Search

Your search keyword '"Andersson, Bodil"' showing total 461 results
Start Over Author "Andersson, Bodil"
461 results on '"Andersson, Bodil"'

1. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)

Author

Stoop, Thomas F., Augustinus, Simone, Björnsson, Bergthor, Tingstedt, Bobby, Andersson, Bodil, Wolfgang, Christopher L., Werner, Jens, Johansen, Karin, Stommel, Martijn W. J., Katz, Matthew H. G., Ghadimi, Michael, House, Michael G., Ghorbani, Poya, Molenaar, I. Quintus, de Wilde, Roeland F., Mieog, J. Sven D., Keck, Tobias, Wellner, Ulrich F., Uhl, Waldemar, Besselink, Marc G., Pitt, Henry A., and Del Chiaro, Marco

Published
2024
Full Text
View/download PDF

2. Transatlantic differences in the use and outcome of minimally invasive pancreatoduodenectomy: an international multi-registry analysis

Author

de Graaf, Nine, Augustinus, Simone, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Davis, Catherine H., Ghadimi, Michael, Gleeson, Elizabeth M., Groot Koerkamp, Bas, Hogg, Melissa E., van Santvoort, Hjalmar C., Tingstedt, Bobby, Uhl, Waldemar, Werner, Jens, Williamsson, Caroline, Zeh, Herbert J., Zureikat, Amer H., Abu Hilal, Mohammad, Pitt, Henry A., Besselink, Marc G., and Keck, Tobias

Published
2024
Full Text
View/download PDF

5. ASO Visual Abstract: Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)

Author

Stoop, Thomas F., Augustinus, Simone, Björnsson, Bergthor, Tingstedt, Bobby, Andersson, Bodil, Wolfgang, Christopher L., Werner, Jens, Johansen, Karin, Stommel, Martijn W. J., Katz, Matthew H. G., Ghadimi, Michael, House, Michael G., Ghorbani, Poya, Molenaar, I. Quintus, de Wilde, Roeland F., Mieog, J. Sven D., Keck, Tobias, Wellner, Ulrich F., Uhl, Waldemar, Besselink, Marc G., Pitt, Henry A., and Del Chiaro, Marco

Published
2024
Full Text
View/download PDF

7. International differences in the selection and outcome of minimally invasive and open distal pancreatectomy: A transatlantic analysis

Author

Johansen, Karin U., Augustinus, Simone, Wellner, Ulrich F., Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Davis, Catherine H., Ghadimi, Michael, Gleeson, Elizabeth M., de Graaf, Nine, Koerkamp, Bas Groot, Pitt, Henry A., van Santvoort, Hjalmar C., Tingstedt, Bobby, Uhl, Waldemar, Werner, Jens, Williamsson, Caroline, Besselink, Marc G., and Keck, Tobias

Published
2024
Full Text
View/download PDF

9. Intraductal papillary neoplasms of the bile ducts: a comparative study of a rare disease in Europe and Nagoya, Japan

Author

Lluís, Núria, Onoe, Shunsuke, Serradilla-Martín, Mario, Achalandabaso, Mar, Mizuno, Takashi, Jehaes, François, Dasari, Bobby V.M., Mambrilla-Herrero, Sara, Sparrelid, Ernesto, Balakrishnan, Anita, Hoogwater, Frederik J.H., Amaral, María J., Andersson, Bodil, Berrevoet, Frederik, Doussot, Alexandre, López-López, Víctor, Detry, Olivier, Pozo, Carlos Domingo-del, Machairas, Nikolaos, Pekli, Damján, Alcázar-López, Cándido F., Asbun, Horacio, Björnsson, Bergthor, Christophides, Thalis, Díez-Caballero, Alberto, Francart, David, Noel, Colin B., Sousa-Silva, Donzília, Toledo-Martínez, Enrique, Tzimas, George N., Yaqub, Sheraz, Yamaguchi, Junpei, Dokmak, Safi, Prieto-Calvo, Mikel, D'Souza, Melroy A., Spiers, Harry V.M., van den Heuvel, Marius C., Charco, Ramón, Lesurtel, Mickaël, Ebata, Tomoki, and Ramia, José M.

Published
2024
Full Text
View/download PDF

10. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial

Author

Aahlin, Eirik Kjus, Bratthäll, Charlotte, Halimi, Asif, Hatlevoll, Ingunn, Heby, Margareta, Kokkola, Arto, Kordes, Maximilian, Lindblad, Stina, Lundgren, Linda, Mortensen, Michael Bau, Mortensen, Kim Erlend, Persson, Jan, Rangelova, Elena, Rønne, Elin, Sandvik, Oddvar Mathias, Søreide, Jon Arne, Vilhav, Caroline, Waardal, Kim, Wennerblom, Johanna, Williamsson, Caroline, Yaqub, Sheraz, Labori, Knut Jørgen, Bratlie, Svein Olav, Andersson, Bodil, Angelsen, Jon-Helge, Biörserud, Christina, Björnsson, Bergthor, Bringeland, Erling Audun, Elander, Nils, Garresori, Herish, Grønbech, Jon Erik, Haux, Johan, Hemmingsson, Oskar, Liljefors, Maria Gustafsson, Myklebust, Tor Åge, Nymo, Linn Såve, Peltola, Katriina, Pfeiffer, Per, Sallinen, Ville, Sandström, Per, Sparrelid, Ernesto, Stenvold, Helge, Søreide, Kjetil, Tingstedt, Bobby, Verbeke, Caroline, Öhlund, Daniel, Klint, Leif, Dueland, Svein, and Lassen, Kristoffer

Published
2024
Full Text
View/download PDF

11. Biliary tract cancer

Author

Søreide, Kjetil, Dopazo, Cristina, Berrevoet, Frederik, Carrion-Alvarez, Lucia, Diaz-Nieto, Rafael, Andersson, Bodil, and Stättner, Stefan

Published
2024
Full Text
View/download PDF

12. The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

Author

Hauke Lang, Smith, Martin, deOliveira, Michelle L., Adair, Anya, Gilg, Stefan, Swijnenburg, Rutger-Jan, Jaekers, Joris, Jegatheeswaran, Santhalingam, Buis, Carlijn, Parks, Rowan, Bockhorn, Maximilian, Conroy, Thierry, Petras, Panagiotis, Primavesi, Florian, Chan, Anthony K.C., Cipriani, Federica, Rubbia-Brandt, Laura, Foster, Lucy, Abdelaal, Amr, Yaqub, Sheraz, Rahbari, Nuh, Fondevila, Constantino, Abradelo, Manuel, Kok, Niels FM., Tejedor, Luis, Martinez-Baena, Dario, Azoulay, Daniel, Maglione, Manuel, Serradilla-Martín, Mario, Azevedo, José, Romano, Fabrizio, Line, Pål-Dag, Forcén, Teresa Abadía, Panis, Yves, Stylianides, Nicolas, Bale, Reto, Quaia, Emilio, Yassin, Nuha, Duque, Victoria, Espin-Basany, Eloy, Mellenhorst, Jarno, Rees, Adam, Adeyeye, Ademola, Tuynman, Jurriaan B., Simillis, Constantinos, Duff, Sarah, Wilson, Richard, De Nardi, Paola, Palmer, Gabriella Jansson, Zakaria, Andee Dzulkarnaen, Perra, Teresa, Porcu, Alberto, Tamini, Nicolò, Kelly, Michael E., Metwally, Islam, Morarasu, Stefan, Carbone, Fabio, Estaire-Gómez, Mercedes, Perez, Elena Martin, Seligmann, Jennifer, Gollins, Simon, Braun, Michael, Hessheimer, Amelia, Alonso, Vincente, Radhakrishna, Ganesh, Alam, Noreen, Camposorias, Constantinos, Barriuoso, Jorge, Ross, Paul, Ba-Ssalamah, Ahmed, Muthu, Sivakumar, Filobbos, Rafik, Nadarajah, Vinotha, Hattab, Annas, Newton, Claire, Barker, Sharon, Sibbald, Jill, Hancock, Jodie, de Liguori Carino, Nicola, Deshpande, Rahul, Lancellotti, Francesco, Paterna, Sandra, Gutierrez-Diez, Marta, Artigas, Consuelo, Siriwardena, Ajith K., Serrablo, Alejandro, Fretland, Åsmund A., Wigmore, Stephen J., Ramia-Angel, Jose M., Malik, Hassan Z., Stättner, Stefan, Søreide, Kjetil, Zmora, Oded, Meijerink, Martijn, Kartalis, Nikolaos, Lesurtel, Mickaël, Verhoef, Cornelis, Balakrishnan, Anita, Gruenberger, Thomas, Jonas, Eduard, Devar, John, Jamdar, Saurabh, Jones, Robert, Hilal, Mohammad A., Andersson, Bodil, Boudjema, Karim, Mullamitha, Saifee, Stassen, Laurents, Dasari, Bobby V.M., Frampton, Adam E., Aldrighetti, Luca, Pellino, Gianluca, Buchwald, Pamela, Gürses, Bengi, Wasserberg, Nir, Gruenberger, Birgit, Spiers, Harry V.M., Jarnagin, William, Vauthey, Jean-Nicholas, Kokudo, Norihiro, Tejpar, Sabine, Valdivieso, Andres, and Adam, René

Published
2023
Full Text
View/download PDF

13. A scoring system for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: a multicenter EUROPEAN validation

Author

Manuel-Vázquez, Alba, Balakrishnan, Anita, Agami, Paul, Andersson, Bodil, Berrevoet, Frederik, Besselink, Marc G., Boggi, Ugo, Caputo, Damiano, Carabias, Alberto, Carrion-Alvarez, Lucia, Franco, Carmen Cepeda, Coppola, Alessandro, Dasari, Bobby V. M., Diaz-Mercedes, Sherley, Feretis, Michail, Fondevila, Constantino, Fusai, Giuseppe Kito, Garcea, Giuseppe, Gonzabay, Victor, Bravo, Miguel Ángel Gómez, Gorris, Myrte, Hendrikx, Bart, Hidalgo-Salinas, Camila, Kadam, Prashant, Karavias, Dimitrios, Kauffmann, Emanuele, Kourdouli, Amar, La Vaccara, Vincenzo, van Laarhoven, Stijn, Leighton, James, Liem, Mike S. L., Machairas, Nikolaos, Magouliotis, Dimitris, Mahmoud, Adel, Marino, Marco V., Massani, Marco, Requena, Paola Melgar, Mentor, Keno, Napoli, Niccolò, Nijhuis, Jorieke H. T., Nikov, Andrej, Nistri, Cristina, Nunes, Victor, Ruiz, Eduardo Ortiz, Pandanaboyana, Sanjay, Saborido, Baltasar Pérez, Pohnán, Radek, Popa, Mariuca, Pérez, Belinda Sánchez, Bueno, Francisco Sánchez, Serrablo, Alejandro, Serradilla-Martín, Mario, Skipworth, James R. A., Soreide, Kjetil, Symeonidis, Dimitris, Zacharoulis, Dimitris, Zelga, Piotr, Aliseda, Daniel, Santiago, María Jesús Castro, Mancilla, Carlos Fernández, Fragua, Raquel Latorre, Hughes, Daniel Llwyd, Llorente, Carmen Payá, Lesurtel, Mickaël, Gallagher, Tom, and Ramia, José Manuel

Published
2022
Full Text
View/download PDF

14. Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study

Author

Abe, Tomoyuki, Abu Hilal, Moh'd, Achalandabaso Boira, Maria del Mar, Adham, Mustapha, Adam, Mohamed, Ahmad, Maryam, Al-Sarireh, Bilal, Albiol, Maite, Alhaboob, Nassir, Alseidi, Adnan, Ammar, Houssem, Anand, Akshay, Andersson, Bodil, Antonakis, Pantelis, Araya, Veronica, Ashley, Stanley W., Atanasov, Georgi, Ausania, Fabio, Balestri, Ricardo, Banerjee, Abhirup, Banerjee, Sudeep, Banting, Simon, Barauskas, Giedrius, Bartsch, Fabian, Belli, Andrea, Beretta, Simona, Berrevoet, Frederik, Bhandari, Ramesh Singh, Blanco Fernandez, Gerardo, Bolm, Louisa, Bonal, Mathieu, Bozkurt, Emre, Braat, Andries E., Bradshaw, Luke, Bramis, Konstantinos, Branes, Alejandro, Burdine, Lyle, Byrne, Matthew, Caceres, Maria, Castro Santiago, Maria Jesus, Chan, Benjamin, Chong, Lynn, Çoker, Ahmet, Conde Rodriguez, Maria, Croagh, Daniel, Crutchley, Alyn, Cutolo, Carmen, D'Hondt, Mathieu, D'Souza, Daniel, Daams, Freek, Dalla Valle, Raffaele, Davide, José, de Bellis, Mario, de Boer, Marieke, de Meyere, Celine, de Reuver, Philip, Dixon, Matthew, Dorovinis, Panagiotis, Echeverría Bauer, Gabriela, Eduarda, Maria, Eker, Hasan, Erdmann, Joris, Erkan, Mert, Felekouras, Evangelos, Felli, Emanuele, Fernandes, Eduardo, Figueroa Rivera, Eduardo, Fulop, Andras, Galun, Daniel, Gerhards, Michael, Ghorbani, Poya, Giannone, Fabio, Gil, Luis, Giorgakis, Emmanouil, Giuffrida, Mario, Giuliante, Felice, Gkekas, Ioannis, Gomez Bravo, Miguel, Groot Koerkamp, Bas, Guevara, Oscar, Guglielmi, Alfredo, Gulla, Aiste, Gupta, Rahul, Gupta, Amit, Gutiérrez, Marta, Hafeez Bhatti, Abu Bakar, Hagendoorn, Jeroen, Hajee, Zain, Hakeem, Abdul Rahman, Hamid, Hytham, Hassen, Sayed, Heinrich, Stefan, Higuchi, Ryota, Hoffman, Daniel, Holroyd, David, Hughes, Daniel, Ivanecz, Arpad, Iype, Satheesh, Jaen Torrejimeno, Isabel, Joglekar, Shantanu, Jones, Robert, Kaczirek, Klaus, Kanhere, Harsh, Kausar, Ambareen, Kee, Zhanyi, Keilson, Jessica, Kleef, Jorg, Klose, Johannes, Knowles, Brett, Koong, Jun Kit, Kumar, Nagappan, Kunnuru, Supreeth, Lakhey, Paleswan Joshi, Laurenzi, Andrea, Lee, Yeong Sing, Leon, Felipe, Leow, Voon Meng, Lequeu, Jean-Baptiste, Lesurtel, Mickael, Lo, Elisabeth, Löb, Stefan, Lockie, Elizabeth, Lodge, Peter, López Garnica, Dolores, Lopez Lopez, Victor, Lundgren, Linda, Machairas, Nikolaos, Maharjan, Dhiresh, Malde, Deep, Martel, Guillaume, Martin, Julie, Mazzola, Michele, Mehrabi, Arianeb, Memeo, Ricardo, Milana, Flavio, Molina, George, Monette, Leah, Morgul, Haluk, Moris, Dimitrios, Morsi-Yeroyannis, Antonios, Mowbray, Nicholas, Mulita, Francesk, Muttillo, Edoardo Maria, Nandasena, Malith, Nashidengo, Pueya Rashid, Nickkholgh, Arash, Noel, Colin Byron, Ohtsuka, Masayuki, Ozolins, Arturs, Pandanaboyana, Sanjay, Pararas, Nikolaos, Parente, Alessandro, Peng, June, Perfecto Valero, Arkaitz, Perinel, Julie, Perivoliotis, Konstatinos, Perra, Teresa, Pessaux, Patrick, Petruch, Natalie, Piccolo, Gaetano, Piros, Laszlo, Porcu, Alberto, Prabakaran, Viswakumar, Prasad, Raj, Prieto Calvo, Mikel, Primavesi, Florian, Pueyo Periz, Eva Maria, Quaglia, Alberto, Ramia Angel, Jose M., Rammohan, Ashwin, Razionale, Francesco, Robles Campos, Ricardo, Roy, Manas, Rozwadowski, Sophie, Ruffolo, Luis, Ruiz, Natalia, Ruzzenante, Andrea, Saadat, Lily, Said, Mohamed Amine, Saladino, Edoardo, Saliba, Gabriel, Sandstrom, Per, Schena, Carlo Alberto, Scholer, Anthony, Schwarz, Christoph, Serafini, Lorenzo, Serrano, Pablo E., Sharma, Deepak, Sheen, Aali, Siddagangaiah, Vishwanath, Silva, Michael, Singh, Saurabh, Siriwardena, Ajith, Skalski, Michal, Smig, Mante, Soliman, Faris, Sonkar, Abhinav Arun, Sousa Silva, Donzília, Sparrelid, Ernesto, Srinivasan, Parthi, Sternby Eilard, Malin, Strobel, Oliver, Stupan, Urban, Suarez-Munoz, Miguel Angel, Subramaniam, Manisekar, Sugiura, Teiichi, Sutcliffe, Robert, Swank, Hilko, Taylor, Lillian, Thapa, Prabin Bikram, The, Catherine, Thepbunchonchai, Asara, Thieu, Caman, Tiwari, Navneet, Torzilli, Guido, Tovikkai, Chutwichai, Trotovsek, Blaz, Tsaramanidis, Savvas, Tsoulfas, Georgios, Uesaka, Katsuhiko, Umar, Garzali, Urbani, Lucio, Vailas, Michail, van Dam, Ronald, van de Boezem, Peter, van Laarhoven, Stijn, Vanagas, Tomas, Van Dooren, Mike, Viennet, Manon, Vigano, Luca, Vijayashanker, Aarathi, Villodre, Celia, Wakai, Toshifumi, Workneh, Aklile, Xu, Li, Yamamoto, Masakazu, Yang, Zhiying, Young, Robert, Zivanovic, Marko, Balakrishnan, Anita, Barmpounakis, Petros, Demiris, Nikolaos, Jah, Asif, Spiers, Harry V.M., Talukder, Shibojit, Martin, Jack L., Gibbs, Paul, Harper, Simon J.F., Huguet, Emmanuel L., Kosmoliaptsis, Vasilis, Liau, Siong S., Praseedom, Raaj K., Basu, Bristi, de Aretxabala, Xavier, Lendoire, Javier, Maithel, Shishir, Serrablo, Alejandro, and Adsay, Volkan

Published
2023
Full Text
View/download PDF

20. Heterogeneity of management practices surrounding operable gallbladder cancer – results of the OMEGA-S international HPB surgical survey

Author

Abe, T., Achalandabaso, M., Adham, M., Ahmet, A., Al-Sarireh, B., Albiol Quer, M., Alconchel, F., Alsammani, M., Alseidi, A., Anand, A., Anselmo, A., Antonakis, P., Arabadzhieva, E., de Aretxabala, X., Aroori, S., Ashley, S., Ausania, F., Banerjee, A., Barabino, M., Bartlett, A., Bartsch, F., Belli, A., Beristain-Hernandez, J., Berrevoet, F., Bhatti, A.B.H., Bhojwani, R., Bjornsson, B., Blaz, T., Byrne, M., Calvo, M.P., Castellanos, J., Castro, M.J., Cavallucci, D., Chang, D., Christodoulis, G., Ciacio, O., Clavien, P.A., Coker, A., Conde-Rodriguez, M., D'Amico, F.E., D'Hondt, M., Daams, F., Dasari, B.V.M., De Bellis, M., de Meijer, V.E., Dede, K., Deiro, G., Delgado, F.J.B., Desai, G., Di Gioia, A., Di Martino, M., Dixon, M., Dorovinis, P., Dumitrascu, T., Ebata, T., Eilard, M.S., Erdmann, J., Erkan, M., Famularo, S., Felli, E., Fergadi, M., Fernandez, G.B., Fox, A., Galodha, S., Galun, D., Ganandha, S., Garcia, R.J.R., Gemenetzis, G., Giannone, F., Gil, L., Giorgakis, E., Giovinazzo, F., Giuffrida, M., Giuliani, T., Giuliante, F., Gkekas, I., Goel, M., Goh, B.K., Gomes, A., Gruenberger, T., Guevara, O., Gulla, A., Gupta, A., Gupta, R., Hakeem, A.R., Hamid, H.K.S., Heinrich, S., Helton, S., Hernandez-Alejandro, R., Heumann, A., Higuchi, R., Hughes, D., Inarejos, B.C., Ivanecz, A., Iwao, Y., Iype, S., Jaen, I., Jie, M.J., Jones, R., Kacirek, K., Kalayarasan, R., Kaldarov, A., Kaman, L., Kanhere, H., Kapoor, V.K., Karanicolas, P., Karayiannakis, A., Kausar, A., Khan, Z.A., Kim, D.-S., Klose, J., Knowles, B., Koh, P.S., Kolodziejczyk, P., Komorowski, A.L., Koong, J.K., Kozyrin, I., Krishna, A., Kron, P., Kumar, N., van Laarhoven, S., Lakhey, P.J., Lanari, J., Laurenzi, A., Leow, V.M., Limbu, Y., Liu, Y.-B., Lob, S., Lolis, E., Lopez-Lopez, V., Lozano, R.C., Lundgren, L., Machairas, N., Magouliotis, D., Mahamid, A., Malde, D., Malek, A., Malik, H., Malleo, G., Marino, M.V., Mayo, S.C., Mazzola, M., Memeo, R., Menon, K., Menzulin, R., Mohan, R., Morgul, H., Moris, D., Mulita, F., Muttillo, E.M., Nahm, C., Nandasena, M., Nashidengo, P.R., Nickkholgh, A., Nikov, A., Noel, C., O'Reilly, D., O'Rourke, T., Ohtsuka, M., Omoshoro-Jones, J.A.O., Pandanaboyana, S., Pararas, N., Patel, R., Patkar, S., Peng, J.S., Perfecto, A., Perinel, J., Perivoliotis, K., Perra, T., Phan, M.T., Piccolo, G., Porcu, A., Primavesi, F., Primrose, J., Pueyo-Periz, E., Radenkovic, D., Rammohan, A., Rowcroft, A., Sakata, J., Saladino, E., Schena, C.A., Scholer, A., Schwarz, C., Serrano, P., Silva, M., Soreide, K., Sparrelid, E., Stattner, S., Sturesson, C., Sugiura, T., Sumo, M., Sutcliffe, R., Teh, C., Teo, J.Y., Tepetes, K., Thapa, P.B., Thepbunchonchai, A., Torres, J.B.P., Torres, O.J.M., Torzili, G., Tovikkai, C., Troncoso, A., Tsoulfas, G., Tuzuher, A., Tzimas, G., Umar, G.I., Urbani, L., Vanagas, T., Varga, Velayutham, V., Vigano, L., Wakai, T., Yang, Z., Yip, V., Zacharoulis, D., Zakharov, E.A., Zimmitti, G., Balakrishnan, Anita, Jah, Asif, Lesurtel, Mickael, Andersson, Bodil, Gibbs, Paul, Harper, Simon J.F., Huguet, Emmanuel L., Kosmoliaptsis, Vasilis, Liau, Siong S., Praseedom, Raaj K., Ramia, Jose M., Branes, Alejandro, Lendoire, Javier, Maithel, Shishir, and Serrablo, Alejandro

Published
2022
Full Text
View/download PDF

22. International Delphi consensus on the management of percutaneous choleystostomy in acute cholecystitis (E-AHPBA, ANS, WSES societies).

Author

Ramia, José M., Serradilla-Martín, Mario, Villodre, Celia, Rubio, Juan J., Rotellar, Fernando, Siriwardena, Ajith K., Wakabayashi, Go, Catena, Fausto, Abe, Tomoyuki, Abe, Yuta, Abu-Zidan, Fikri, López, Cándido F. Alcázar, Amemiya, Ryusuke, Andersson, Bodil, Ansaloni, Luca, Balakrishnan, Anita, Balogh, Zsolt J., Carbonell-Morote, Silvia, Coker, Ahmet, and Damaskos, Dimitrios

Subjects
CONSENSUS (Social sciences), MEDICAL protocols, POSTOPERATIVE care, DESCRIPTIVE statistics, SURGICAL complications, SURVEYS, DELPHI method, CHOLECYSTITIS, CHOLECYSTOSTOMY, GROUP process
Abstract

Background: There has been a progressive increase in the use of percutaneous cholecystostomy (PC) in acute cholecystitis (AC) over the last decades due to population aging, and the support of guidelines (Tokyo Guidelines (TG), World Society of Emergency Surgery (WSES) Guidelines) as a valid therapeutical option. However, there are many unanswered questions about the management of PCs. An international consensus on indications and PC management using Delphi methodology with contributions from experts from three surgical societies (EAHPBA, ANS, WSES) have been performed. Methods: A two-round Delphi consensus, which included 27 questions, was sent to key opinion leaders in AC. Participants were asked to indicate their 'agreement/disagreement' using a 5-point Likert scale. Survey items with less than 70% consensus were excluded from the second round. For inclusion in the final recommendations, each survey item had to have reached a group consensus (≥ 70% agreement) by the end of the two survey rounds. Results: 54 completed both rounds (82% of invitees). Six questions got > 70% and are included in consensus recommendations: In patients with acute cholecystitis, when there is a clear indication of PC, it is not necessary to wait 48 h to be carried out; Surgery is the first therapeutic option for the TG grade II acute cholecystitis in a patient suitable for surgery; Before PC removal a cholangiography should be done; There is no indication for PC in Tokyo Guidelines (TG) grade I patients; Transhepatic approach is the route of choice for PC; and after PC, laparoscopic cholecystectomy is the preferred approach (93.1%). Conclusions: Only six statements about PC management after AC got an international consensus. An international guideline about the management of PCs are necessary. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

23. Surveillance after surgery for pancreatic cancer: a global scoping review of guidelines and a nordic Survey of contemporary practice.

Author

Ansari, Daniel, Søreide, Kjetil, Andersson, Bodil, Hansen, Carsten Palnæs, Seppänen, Hanna, Sparrelid, Ernesto, Labori, Knut Jørgen, Kirkegård, Jakob, Kauhanen, Saila, Månsson, Christopher, Nymo, Linn Såve, Nortunen, Minna, Björnsson, Bergthor, Kivivuori, Antti, Tingstedt, Bobby, Bratlie, Svein-Olav, Waardal, Kim, Laukkarinen, Johanna, Halimi, Asif, and Lindberg, Hannes

Subjects
CA 19-9 test, PANCREATIC cancer, WATCHFUL waiting, ONCOLOGIC surgery, SURGICAL excision
Abstract

Objectives: Most patients with pancreatic cancer who have undergone surgical resection eventually develop disease recurrence. ‍This study aimed to investigate whether there is evidence to support routine surveillance after pancreatic cancer surgery, with a secondary aim of analyzing the implementation of surveillance strategies in the Nordic countries. Materials and Methods: A scoping review was conducted to identify clinical practice guidelines globally and research studies relating to surveillance after pancreatic cancer resection. This was followed by a survey among 20 pancreatic units from four Nordic countries to assess their current practice of follow-up for operated patients. Results: Altogether 16 clinical practice guidelines and 17 research studies were included. The guidelines provided inconsistent recommendations regarding postoperative surveillance of pancreatic cancer. The clinical research data were mainly based on retrospective cohort studies with low level of evidence and lead-time bias was not addressed. Active surveillance was recommended in Sweden and Denmark, but not in Norway beyond the post-operative/adjuvant period. Finland had no national recommendations for surveillance. The Nordic survey revealed a wide variation in reported practice among the different units. About 75% (15 of 20 units) performed routine postoperative surveillance. Routine CA 19-9 testing was used by 80% and routine CT by 67% as part of surveillance. About 73% of centers continued follow-up until 5 years postoperatively. Conclusion: Evidence for routine long-term (i.e. 5 years) surveillance after pancreatic cancer surgery remains limited. Most pancreatic units in the Nordic countries conduct regular follow-up, but protocols vary. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

25. International differences in the selection and outcome of minimally invasive and open distal pancreatectomy:A transatlantic analysis

Author

Johansen, Karin U., Augustinus, Simone, Wellner, Ulrich F., Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Davis, Catherine H., Ghadimi, Michael, Gleeson, Elizabeth M., de Graaf, Nine, Koerkamp, Bas Groot, Pitt, Henry A., van Santvoort, Hjalmar C., Tingstedt, Bobby, Uhl, Waldemar, Werner, Jens, Williamsson, Caroline, Besselink, Marc G., Keck, Tobias, Johansen, Karin U., Augustinus, Simone, Wellner, Ulrich F., Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Davis, Catherine H., Ghadimi, Michael, Gleeson, Elizabeth M., de Graaf, Nine, Koerkamp, Bas Groot, Pitt, Henry A., van Santvoort, Hjalmar C., Tingstedt, Bobby, Uhl, Waldemar, Werner, Jens, Williamsson, Caroline, Besselink, Marc G., and Keck, Tobias

Abstract

Background: The efficacy and safety of minimally invasive distal pancreatectomy have been confirmed by randomized trials, but current patient selection and outcome of minimally invasive distal pancreatectomy in large international cohorts is unknown. This study aimed to compare the use and outcome of minimally invasive distal pancreatectomy in North America, the Netherlands, Germany, and Sweden. Methods: All patients in the 4 Global Audits on Pancreatic Surgery Group (GAPASURG) registries who underwent minimally invasive distal pancreatectomy or open distal pancreatectomy during 2014–2020 were included. Results: Overall, 20,158 distal pancreatectomies were included, of which 7,316 (36%) were minimally invasive distal pancreatectomies. Use of minimally invasive distal pancreatectomy varied from 29% to 54% among registries, of which 13% to 35% were performed robotically. Both the use of minimally invasive distal pancreatectomy and robotic surgery were the highest in the Netherlands. Patients undergoing minimally invasive distal pancreatectomy tended to have a younger age (Germany and Sweden), female sex (North America, Germany), higher body mass index (North America, the Netherlands, Germany), lower comorbidity classification (North America, Germany, Sweden), lower performance status (Germany), and lower rate of pancreatic adenocarcinoma (all). The minimally invasive distal pancreatectomy group had fewer vascular resections (all) and lower rates of severe complications and mortality (North America, Germany). In the multivariable regression analysis, country was associated with severe complications but not with 30-day mortality. Minimally invasive distal pancreatectomy was associated with a lower risk of 30-day mortality compared with open distal pancreatectomy (odds ratio 1.633, 95% CI 1.159–2.300, P = .005). Conclusions: Considerable disparities were seen in the use of minimally invasive

Published
2024

26. Surgical Outcome After Distal Pancreatectomy With and Without Portomesenteric Venous Resection in Patients with Pancreatic Adenocarcinoma:A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)

Author

Stoop, Thomas F., Augustinus, Simone, Bjornsson, Bergthor, Tingstedt, Bobby, Andersson, Bodil, Wolfgang, Christopher L., Werner, Jens, Johansen, Karin, Stommel, Martijn W. J., Katz, Matthew H. G., Ghadimi, Michael, House, Michael G., Ghorbani, Poya, Molenaar, I. Quintus, de Wilde, Roeland F., Mieog, J. Sven D., Keck, Tobias, Wellner, Ulrich F., Uhl, Waldemar, Besselink, Marc G., Pitt, Henry A., Del Chiaro, Marco, Stoop, Thomas F., Augustinus, Simone, Bjornsson, Bergthor, Tingstedt, Bobby, Andersson, Bodil, Wolfgang, Christopher L., Werner, Jens, Johansen, Karin, Stommel, Martijn W. J., Katz, Matthew H. G., Ghadimi, Michael, House, Michael G., Ghorbani, Poya, Molenaar, I. Quintus, de Wilde, Roeland F., Mieog, J. Sven D., Keck, Tobias, Wellner, Ulrich F., Uhl, Waldemar, Besselink, Marc G., Pitt, Henry A., and Del Chiaro, Marco

Abstract

BackgroundPancreatic adenocarcinoma located in the pancreatic body might require a portomesenteric venous resection (PVR), but data regarding surgical risks after distal pancreatectomy (DP) with PVR are sparse. Insight into additional surgical risks of DP-PVR could support preoperative counseling and intraoperative decision making. This study aimed to provide insight into the surgical outcome of DP-PVR, including its potential risk elevation over standard DP.MethodsWe conducted a retrospective, multicenter study including all patients with pancreatic adenocarcinoma who underwent DP +/- PVR (2018-2020), registered in four audits for pancreatic surgery from North America, Germany, Sweden, and The Netherlands. Patients who underwent concomitant arterial and/or multivisceral resection(s) were excluded. Predictors for in-hospital/30-day major morbidity and mortality were investigated by logistic regression, correcting for each audit.ResultsOverall, 2924 patients after DP were included, of whom 241 patients (8.2%) underwent DP-PVR. Rates of major morbidity (24% vs. 18%; p = 0.024) and post-pancreatectomy hemorrhage grade B/C (10% vs. 3%; p = 0.041) were higher after DP-PVR compared with standard DP. Mortality after DP-PVR and standard DP did not differ significantly (2% vs. 1%; p = 0.542). Predictors for major morbidity were PVR (odds ratio [OR] 1.500, 95% confidence interval [CI] 1.086-2.071) and conversion from minimally invasive to open surgery (OR 1.420, 95% CI 1.032-1.970). Predictors for mortality were higher age (OR 1.087, 95% CI 1.045-1.132), chronic obstructive pulmonary disease (OR 4.167, 95% CI 1.852-9.374), and conversion from minimally invasive to open surgery (OR 2.919, 95% CI 1.197-7.118), whereas concomitant PVR was not associated with mortality.ConclusionsPVR during DP for pancreatic adenocarcinoma in the pancreatic body is associated with increased morbidity, but can be performed safely in terms of mortality.

Published
2024

27. ASO Author Reflections:Distal Pancreatectomy With and Without Portomesenteric Venous Resection for Pancreatic Adenocarcinoma: A Transatlantic Evaluation of Patients in North America, Germany, Sweden, and The Netherlands (GAPASURG)

Author

Stoop, Thomas F., Augustinus, Simone, Andersson, Bodil, Ghorbani, Poya, Wellner, Ulrich F., Uhl, Waldemar, Besselink, Marc G., Pitt, Henry A., Del Chiaro, Marco, Bjoernsson, Bergthor, Tingstedt, Bobby, Wolfgang, Christopher L., Werner, Jens, Johansen, Karin, Stommel, Martijn W. J., Katz, Matthew H. G., Ghadimi, Michael, House, Michael G., Molenaar, I. Quintus, de Wilde, Roeland F., Mieog, J. Sven D., Keck, Tobias, Mackay, Tara M., Franco, Salvador Rodriguez, van Dieren, Susan, Stoop, Thomas F., Augustinus, Simone, Andersson, Bodil, Ghorbani, Poya, Wellner, Ulrich F., Uhl, Waldemar, Besselink, Marc G., Pitt, Henry A., Del Chiaro, Marco, Bjoernsson, Bergthor, Tingstedt, Bobby, Wolfgang, Christopher L., Werner, Jens, Johansen, Karin, Stommel, Martijn W. J., Katz, Matthew H. G., Ghadimi, Michael, House, Michael G., Molenaar, I. Quintus, de Wilde, Roeland F., Mieog, J. Sven D., Keck, Tobias, Mackay, Tara M., Franco, Salvador Rodriguez, and van Dieren, Susan

Published
2024

28. Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1) : a multicentre, randomised, phase 2 trial

Author

Labori, Knut Jørgen, Bratlie, Svein Olav, Andersson, Bodil, Angelsen, Jon-Helge, Biörserud, Christina, Björnsson, Bergthor, Bringeland, Erling Audun, Elander, Nils, Garresori, Herish, Grønbech, Jon Erik, Haux, Johan, Hemmingsson, Oskar, Gustafsson Liljefors, Maria, Myklebust, Tor Åge, Nymo, Linn Såve, Peltola, Katriina, Pfeiffer, Per, Sallinen, Ville, Sandström, Per, Sparrelid, Ernesto, Stenvold, Helge, Søreide, Kjetil, Tingstedt, Bobby, Verbeke, Caroline, Öhlund, Daniel, Klint, Leif, Dueland, Svein, Lassen, Kristoffer, Aahlin, Eirik Kjus, Bratthäll, Charlotte, Halimi, Asif, Hatlevoll, Ingunn, Heby, Margareta, Kokkola, Arto, Kordes, Maximilian, Lindblad, Stina, Lundgren, Linda, Mortensen, Michael Bau, Mortensen, Kim Erlend, Persson, Jan, Rangelova, Elena, Rønne, Elin, Sandvik, Oddvar Mathias, Søreide, Jon Arne, Vilhav, Caroline, Waardal, Kim, Wennerblom, Johanna, Williamsson, Caroline, Yaqub, Sheraz, Labori, Knut Jørgen, Bratlie, Svein Olav, Andersson, Bodil, Angelsen, Jon-Helge, Biörserud, Christina, Björnsson, Bergthor, Bringeland, Erling Audun, Elander, Nils, Garresori, Herish, Grønbech, Jon Erik, Haux, Johan, Hemmingsson, Oskar, Gustafsson Liljefors, Maria, Myklebust, Tor Åge, Nymo, Linn Såve, Peltola, Katriina, Pfeiffer, Per, Sallinen, Ville, Sandström, Per, Sparrelid, Ernesto, Stenvold, Helge, Søreide, Kjetil, Tingstedt, Bobby, Verbeke, Caroline, Öhlund, Daniel, Klint, Leif, Dueland, Svein, Lassen, Kristoffer, Aahlin, Eirik Kjus, Bratthäll, Charlotte, Halimi, Asif, Hatlevoll, Ingunn, Heby, Margareta, Kokkola, Arto, Kordes, Maximilian, Lindblad, Stina, Lundgren, Linda, Mortensen, Michael Bau, Mortensen, Kim Erlend, Persson, Jan, Rangelova, Elena, Rønne, Elin, Sandvik, Oddvar Mathias, Søreide, Jon Arne, Vilhav, Caroline, Waardal, Kim, Wennerblom, Johanna, Williamsson, Caroline, and Yaqub, Sheraz

Abstract

Background In patients undergoing resection for pancreatic cancer, adjuvant modified fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX) improves overall survival compared with alternative chemotherapy regimens. We aimed to compare the efficacy and safety of neoadjuvant FOLFIRINOX with the standard strategy of upfront surgery in patients with resectable pancreatic ductal adenocarcinoma. Methods NORPACT-1 was a multicentre, randomised, phase 2 trial done in 12 hospitals in Denmark, Finland, Norway, and Sweden. Eligible patients were aged 18 years or older, with a WHO performance status of 0 or 1, and had a resectable tumour of the pancreatic head radiologically strongly suspected to be pancreatic adenocarcinoma. Participants were randomly assigned (3:2 before October, 2018, and 1:1 after) to the neoadjuvant FOLFIRINOX group or upfront surgery group. Patients in the neoadjuvant FOLFIRINOX group received four neoadjuvant cycles of FOLFIRINOX (oxaliplatin 85 mg/m2, irinotecan 180 mg/m2, leucovorin 400 mg/m2, and fluorouracil 400 mg/m2 bolus then 2400 mg/m2 over 46 h on day 1 of each 14-day cycle), followed by surgery and adjuvant chemotherapy. Patients in the upfront surgery group underwent surgery and then received adjuvant chemotherapy. Initially, adjuvant chemotherapy was gemcitabine plus capecitabine (gemcitabine 1000 mg/m2 over 30 min on days 1, 8, and 15 of each 28-day cycle and capecitabine 830 mg/m2 twice daily for 3 weeks with 1 week of rest in each 28-day cycle; four cycles in the neoadjuvant FOLFIRINOX group, six cycles in the upfront surgery group). A protocol amendment was subsequently made to permit use of adjuvant modified FOLFIRINOX (oxaliplatin 85 mg/m2, irinotecan 150 mg/m2, leucovorin 400 mg/m2, and fluorouracil 2400 mg/m2 over 46 h on day 1 of each 14-day cycle; eight cycles in the neoadjuvant FOLFIRINOX group, 12 cycles in the upfront surgery group). Randomisation was performed with a computerised algorithm that stratified for each pa, Correspondence to: Prof Knut Jørgen Labori, Department of Hepato Pancreato Biliary Surgery, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, N-0372 Oslo, NorwayFunding: Norwegian Cancer Society, South Eastern Norwegian Health Authority, The Sjöberg Foundation, and Helsinki University Hospital Research Grants.

Published
2024
Full Text
View/download PDF

29. Impact of Neoadjuvant Therapy for Pancreatic Cancer: Transatlantic Trend and Postoperative Outcomes Analysis

Author

Davis, Catherine H., Augustinus, Simone, de Graaf, Nine, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Gleeson, Elizabeth M., van Santvoort, Hjalmar C., Tingstedt, Bobby, Williamsson, Caroline, Keck, Tobias, Besselink, Marc G., Koerkamp, Bas Groot, Pitt, Henry A., Davis, Catherine H., Augustinus, Simone, de Graaf, Nine, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Gleeson, Elizabeth M., van Santvoort, Hjalmar C., Tingstedt, Bobby, Williamsson, Caroline, Keck, Tobias, Besselink, Marc G., Koerkamp, Bas Groot, and Pitt, Henry A.

Abstract

BACKGROUND:The introduction of modern chemotherapy a decade ago has led to increased use of neoadjuvant therapy (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC). A recent North American study demonstrated increased use of NAT and improved operative outcomes in patients with PDAC. The aims of this study were to compare the use of NAT and short-term outcomes in patients with PDAC undergoing pancreatoduodenectomy (PD) among registries from the US and Canada, Germany, the Netherlands, and Sweden. STUDY DESIGN:Databases from 2 multicenter (voluntary) and 2 nationwide (mandatory) registries were queried from 2018 to 2020. Patients undergoing PD for PDAC were compared based on the use of upfront surgery vs NAT. Adoption of NAT was measured in each country over time. Thirty-day outcomes, including the composite measure (ideal outcomes), were compared by multivariable analyses. Sensitivity analyses of patients undergoing vascular resection were performed. RESULTS:Overall, 11,402 patients underwent PD for PDAC with 33.7% of patients receiving NAT. The use of NAT increased steadily from 28.3% in 2018 to 38.5% in 2020 (p < 0.0001). However, use of NAT varied widely by country: the US (46.8%), the Netherlands (44.9%), Sweden (11.0%), and Germany (7.8%). On multivariable analysis, NAT was significantly (p < 0.01) associated with reduced rates of serious morbidity, clinically relevant pancreatic fistulae, reoperations, and increased ideal outcomes. These associations remained on sensitivity analysis of patients undergoing vascular resection. CONCLUSIONS:NAT before PD for pancreatic cancer varied widely among 4 Western audits yet increased by 26% during 3 years. NAT was associated with improved short-term outcomes.

Published
2024
Full Text
View/download PDF

30. Impact of Neoadjuvant Therapy for Pancreatic Cancer:Transatlantic Trend and Postoperative Outcomes Analysis

Author

Davis, Catherine H., Augustinus, Simone, de Graaf, Nine, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Gleeson, Elizabeth M., van Santvoort, Hjalmar C., Tingstedt, Bobby, Williamsson, Caroline, Keck, Tobias, Besselink, Marc G., Koerkamp, Bas Groot, Pitt, Henry A., Davis, Catherine H., Augustinus, Simone, de Graaf, Nine, Wellner, Ulrich F., Johansen, Karin, Andersson, Bodil, Beane, Joal D., Björnsson, Bergthor, Busch, Olivier R., Gleeson, Elizabeth M., van Santvoort, Hjalmar C., Tingstedt, Bobby, Williamsson, Caroline, Keck, Tobias, Besselink, Marc G., Koerkamp, Bas Groot, and Pitt, Henry A.

Abstract

BACKGROUND: The introduction of modern chemotherapy a decade ago has led to increased use of neoadjuvant therapy (NAT) in patients with pancreatic ductal adenocarcinoma (PDAC). A recent North American study demonstrated increased use of NAT and improved operative outcomes in patients with PDAC. The aims of this study were to compare the use of NAT and short-term outcomes in patients with PDAC undergoing pancreatoduodenectomy (PD) among registries from the US and Canada, Germany, the Netherlands, and Sweden. STUDY DESIGN: Databases from 2 multicenter (voluntary) and 2 nationwide (mandatory) registries were queried from 2018 to 2020. Patients undergoing PD for PDAC were compared based on the use of upfront surgery vs NAT. Adoption of NAT was measured in each country over time. Thirty-day outcomes, including the composite measure (ideal outcomes), were compared by multivariable analyses. Sensitivity analyses of patients undergoing vascular resection were performed. RESULTS: Overall, 11,402 patients underwent PD for PDAC with 33.7% of patients receiving NAT. The use of NAT increased steadily from 28.3% in 2018 to 38.5% in 2020 (p < 0.0001). However, use of NAT varied widely by country: the US (46.8%), the Netherlands (44.9%), Sweden (11.0%), and Germany (7.8%). On multivariable analysis, NAT was significantly (p < 0.01) associated with reduced rates of serious morbidity, clinically relevant pancreatic fistulae, reoperations, and increased ideal outcomes. These associations remained on sensitivity analysis of patients undergoing vascular resection. CONCLUSIONS: NAT before PD for pancreatic cancer varied widely among 4 Western audits yet increased by 26% during 3 years. NAT was associated with improved short-term outcomes.

Published
2024

39. Ideal outcome after pancreatoduodenectomy: a transatlantic evaluation of a harmonised composite outcome measure

Author

Augustinus, Simone, primary, Mackay, Tara M., additional, Andersson, Bodil, additional, Beane, Joal D., additional, Busch, Olivier R.C., additional, Gleeson, Elizabeth M., additional, Koerkamp, Bas Groot, additional, Keck, Tobias, additional, van Santvoort, Hjalmar C., additional, Tingstedt, Bobby, additional, Wellner, Ulrich F., additional, Williamsson, Caroline, additional, Besselink, Marc G., additional, and Pitt, Henry A., additional

Published
2023
Full Text
View/download PDF

45. Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

Author

Siriwardena, Ajith K, primary, Serrablo, Alejandro, additional, Fretland, Åsmund Avdem, additional, Wigmore, Stephen J, additional, Ramia-Angel, Jose Manuel, additional, Malik, Hassan Z, additional, Stättner, Stefan, additional, Søreide, Kjetil, additional, Zmora, Oded, additional, Meijerink, Martijn, additional, Kartalis, Nikolaos, additional, Lesurtel, Mickaёl, additional, Verhoef, Kees, additional, Balakrishnan, Anita, additional, Gruenberger, Thomas, additional, Jonas, Eduard, additional, Devar, John, additional, Jamdar, Saurabh, additional, Jones, Robert, additional, Hilal, Mohammad Abu, additional, Andersson, Bodil, additional, Boudjema, Karim, additional, Mullamitha, Saifee, additional, Stassen, Laurents, additional, Dasari, Bobby V M, additional, Frampton, Adam E, additional, Aldrighetti, Luca, additional, Pellino, Gianluca, additional, Buchwald, Pamela, additional, Gürses, Bengi, additional, Wasserberg, Nir, additional, Gruenberger, Birgit, additional, Spiers, Harry V M, additional, Jarnagin, William, additional, Vauthey, Jean-Nicholas, additional, Kokudo, Norihiro, additional, Tejpar, Sabine, additional, Valdivieso, Andres, additional, and Adam, René, additional

Published
2023
Full Text
View/download PDF

47. Cholecystectomy and ERCP in pregnancy: a nationwide register-based study.

Author

Hedström, Jonas, Nilsson, Johan, and Andersson, Bodil

Abstract

Objective: The objective was to examine the outcomes of cholecystectomy and endoscopic retrograde cholangiopancreatography (ERCP) during pregnancy and compare these outcomes with those in nonpregnant women of fertile age. Summary background data: Although both laparoscopic cholecystectomy and ERCP are considered safe and feasible in pregnant patients, there is still concern and uncertainty regarding gallstone intervention during pregnancy. This study aimed to investigate outcomes in pregnant patients compared to outcomes in nonpregnant patients. Methods: Data on all female patients aged 18-45 years were retrieved from the Swedish Registry for Gallstone Surgery and Endoscopic Retrograde Cholangiopancreatography. The patients were divided into groups according to intervention: cholecystectomy, ERCP, or a combination thereof. Differences between pregnant and nonpregnant patients were analyzed. Results: A total of 21 328 patients were included, with 291 cholecystectomy and 63 ERCP procedures performed in pregnant patients. At the 30-day follow-up, more complications after cholecystectomy were registered for pregnant patients. However, pregnancy was not a significant risk factor for adverse events when adjusting for previous complicated gallstone disease, intraoperative complications, emergency surgery, and common bile duct stones. There were no differences in outcomes when comparing cholecystectomy among the different trimesters. ERCP had no significant effect on outcomes at the 30-day follow-up. Conclusion: Cholecystectomy, ERCP, and combinations thereof are safe during pregnancy. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

49. Surgical outcomes of gallbladder cancer: the OMEGA retrospective, multicentre, international cohort study

Author

Balakrishnan, Anita, primary, Barmpounakis, Petros, additional, Demiris, Nikolaos, additional, Jah, Asif, additional, Spiers, Harry V.M., additional, Talukder, Shibojit, additional, Martin, Jack L., additional, Gibbs, Paul, additional, Harper, Simon J.F., additional, Huguet, Emmanuel L., additional, Kosmoliaptsis, Vasilis, additional, Liau, Siong S., additional, Praseedom, Raaj K., additional, Basu, Bristi, additional, de Aretxabala, Xavier, additional, Lendoire, Javier, additional, Maithel, Shishir, additional, Branes, Alejandro, additional, Andersson, Bodil, additional, Serrablo, Alejandro, additional, Adsay, Volkan, additional, Abe, Tomoyuki, additional, Abu Hilal, Moh'd, additional, Achalandabaso Boira, Maria del Mar, additional, Adham, Mustapha, additional, Adam, Mohamed, additional, Ahmad, Maryam, additional, Al-Sarireh, Bilal, additional, Albiol, Maite, additional, Alhaboob, Nassir, additional, Alseidi, Adnan, additional, Ammar, Houssem, additional, Anand, Akshay, additional, Antonakis, Pantelis, additional, Araya, Veronica, additional, Ashley, Stanley W., additional, Atanasov, Georgi, additional, Ausania, Fabio, additional, Balestri, Ricardo, additional, Banerjee, Abhirup, additional, Banerjee, Sudeep, additional, Banting, Simon, additional, Barauskas, Giedrius, additional, Bartsch, Fabian, additional, Belli, Andrea, additional, Beretta, Simona, additional, Berrevoet, Frederik, additional, Bhandari, Ramesh Singh, additional, Blanco Fernandez, Gerardo, additional, Bolm, Louisa, additional, Bonal, Mathieu, additional, Bozkurt, Emre, additional, Braat, Andries E., additional, Bradshaw, Luke, additional, Bramis, Konstantinos, additional, Burdine, Lyle, additional, Byrne, Matthew, additional, Caceres, Maria, additional, Castro Santiago, Maria Jesus, additional, Chan, Benjamin, additional, Chong, Lynn, additional, Çoker, Ahmet, additional, Conde Rodriguez, Maria, additional, Croagh, Daniel, additional, Crutchley, Alyn, additional, Cutolo, Carmen, additional, D'Hondt, Mathieu, additional, D'Souza, Daniel, additional, Daams, Freek, additional, Dalla Valle, Raffaele, additional, Davide, José, additional, de Bellis, Mario, additional, de Boer, Marieke, additional, de Meyere, Celine, additional, de Reuver, Philip, additional, Dixon, Matthew, additional, Dorovinis, Panagiotis, additional, Echeverría Bauer, Gabriela, additional, Eduarda, Maria, additional, Eker, Hasan, additional, Erdmann, Joris, additional, Erkan, Mert, additional, Felekouras, Evangelos, additional, Felli, Emanuele, additional, Fernandes, Eduardo, additional, Figueroa Rivera, Eduardo, additional, Fulop, Andras, additional, Galun, Daniel, additional, Gerhards, Michael, additional, Ghorbani, Poya, additional, Giannone, Fabio, additional, Gil, Luis, additional, Giorgakis, Emmanouil, additional, Giuffrida, Mario, additional, Giuliante, Felice, additional, Gkekas, Ioannis, additional, Gomez Bravo, Miguel, additional, Groot Koerkamp, Bas, additional, Guevara, Oscar, additional, Guglielmi, Alfredo, additional, Gulla, Aiste, additional, Gupta, Rahul, additional, Gupta, Amit, additional, Gutiérrez, Marta, additional, Hafeez Bhatti, Abu Bakar, additional, Hagendoorn, Jeroen, additional, Hajee, Zain, additional, Hakeem, Abdul Rahman, additional, Hamid, Hytham, additional, Hassen, Sayed, additional, Heinrich, Stefan, additional, Higuchi, Ryota, additional, Hoffman, Daniel, additional, Holroyd, David, additional, Hughes, Daniel, additional, Ivanecz, Arpad, additional, Iype, Satheesh, additional, Jaen Torrejimeno, Isabel, additional, Joglekar, Shantanu, additional, Jones, Robert, additional, Kaczirek, Klaus, additional, Kanhere, Harsh, additional, Kausar, Ambareen, additional, Kee, Zhanyi, additional, Keilson, Jessica, additional, Kleef, Jorg, additional, Klose, Johannes, additional, Knowles, Brett, additional, Koong, Jun Kit, additional, Kumar, Nagappan, additional, Kunnuru, Supreeth, additional, Lakhey, Paleswan Joshi, additional, Laurenzi, Andrea, additional, Lee, Yeong Sing, additional, Leon, Felipe, additional, Leow, Voon Meng, additional, Lequeu, Jean-Baptiste, additional, Lesurtel, Mickael, additional, Lo, Elisabeth, additional, Löb, Stefan, additional, Lockie, Elizabeth, additional, Lodge, Peter, additional, López Garnica, Dolores, additional, Lopez Lopez, Victor, additional, Lundgren, Linda, additional, Machairas, Nikolaos, additional, Maharjan, Dhiresh, additional, Malde, Deep, additional, Martel, Guillaume, additional, Martin, Julie, additional, Mazzola, Michele, additional, Mehrabi, Arianeb, additional, Memeo, Ricardo, additional, Milana, Flavio, additional, Molina, George, additional, Monette, Leah, additional, Morgul, Haluk, additional, Moris, Dimitrios, additional, Morsi-Yeroyannis, Antonios, additional, Mowbray, Nicholas, additional, Mulita, Francesk, additional, Muttillo, Edoardo Maria, additional, Nandasena, Malith, additional, Nashidengo, Pueya Rashid, additional, Nickkholgh, Arash, additional, Noel, Colin Byron, additional, Ohtsuka, Masayuki, additional, Ozolins, Arturs, additional, Pandanaboyana, Sanjay, additional, Pararas, Nikolaos, additional, Parente, Alessandro, additional, Peng, June, additional, Perfecto Valero, Arkaitz, additional, Perinel, Julie, additional, Perivoliotis, Konstatinos, additional, Perra, Teresa, additional, Pessaux, Patrick, additional, Petruch, Natalie, additional, Piccolo, Gaetano, additional, Piros, Laszlo, additional, Porcu, Alberto, additional, Prabakaran, Viswakumar, additional, Prasad, Raj, additional, Prieto Calvo, Mikel, additional, Primavesi, Florian, additional, Pueyo Periz, Eva Maria, additional, Quaglia, Alberto, additional, Ramia Angel, Jose M., additional, Rammohan, Ashwin, additional, Razionale, Francesco, additional, Robles Campos, Ricardo, additional, Roy, Manas, additional, Rozwadowski, Sophie, additional, Ruffolo, Luis, additional, Ruiz, Natalia, additional, Ruzzenante, Andrea, additional, Saadat, Lily, additional, Said, Mohamed Amine, additional, Saladino, Edoardo, additional, Saliba, Gabriel, additional, Sandstrom, Per, additional, Schena, Carlo Alberto, additional, Scholer, Anthony, additional, Schwarz, Christoph, additional, Serafini, Lorenzo, additional, Serrano, Pablo E., additional, Sharma, Deepak, additional, Sheen, Aali, additional, Siddagangaiah, Vishwanath, additional, Silva, Michael, additional, Singh, Saurabh, additional, Siriwardena, Ajith, additional, Skalski, Michal, additional, Smig, Mante, additional, Soliman, Faris, additional, Sonkar, Abhinav Arun, additional, Sousa Silva, Donzília, additional, Sparrelid, Ernesto, additional, Srinivasan, Parthi, additional, Sternby Eilard, Malin, additional, Strobel, Oliver, additional, Stupan, Urban, additional, Suarez-Munoz, Miguel Angel, additional, Subramaniam, Manisekar, additional, Sugiura, Teiichi, additional, Sutcliffe, Robert, additional, Swank, Hilko, additional, Taylor, Lillian, additional, Thapa, Prabin Bikram, additional, The, Catherine, additional, Thepbunchonchai, Asara, additional, Thieu, Caman, additional, Tiwari, Navneet, additional, Torzilli, Guido, additional, Tovikkai, Chutwichai, additional, Trotovsek, Blaz, additional, Tsaramanidis, Savvas, additional, Tsoulfas, Georgios, additional, Uesaka, Katsuhiko, additional, Umar, Garzali, additional, Urbani, Lucio, additional, Vailas, Michail, additional, van Dam, Ronald, additional, van de Boezem, Peter, additional, van Laarhoven, Stijn, additional, Vanagas, Tomas, additional, Van Dooren, Mike, additional, Viennet, Manon, additional, Vigano, Luca, additional, Vijayashanker, Aarathi, additional, Villodre, Celia, additional, Wakai, Toshifumi, additional, Workneh, Aklile, additional, Xu, Li, additional, Yamamoto, Masakazu, additional, Yang, Zhiying, additional, Young, Robert, additional, and Zivanovic, Marko, additional

Published
2023
Full Text
View/download PDF

50. Intraductal papillary neoplasms of the bile duct: a European retrospective multicenter observational study (EUR-IPNB study)

Author

Lluís, Núria, primary, Serradilla-Martín, Mario, additional, Achalandabaso, Mar, additional, Jehaes, François, additional, Dasari, Bobby V.M., additional, Mambrilla-Herrero, Sara, additional, Sparrelid, Ernesto, additional, Balakrishnan, Anita, additional, Hoogwater, Frederik J.H., additional, Amaral, Maria J., additional, Andersson, Bodil, additional, Berrevoet, Frederik, additional, Doussot, Alexandre, additional, López-López, Víctor, additional, Alsammani, Mohammedsuror, additional, Detry, Olivier, additional, Domingo-del Pozo, Carlos, additional, Machairas, Nikolaos, additional, Pekli, Damján, additional, Alcázar-López, Cándido F., additional, Asbun, Horacio, additional, Björnsson, Bergthor, additional, Christophides, Thalis, additional, Díez-Caballero, Alberto, additional, Francart, David, additional, Noel, Colin B., additional, Sousa-Silva, Donzília, additional, Toledo-Martínez, Enrique, additional, Tzimas, George N., additional, Yaqub, Sheraz, additional, Cauchy, François, additional, Prieto-Calvo, Mikel, additional, D’Souza, Melroy A., additional, Spiers, Harry V.M., additional, van den Heuvel, Marius C., additional, Charco, Ramón, additional, Lesurtel, Mickaël, additional, and Ramia, José M., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results